Metabolic Alterations in Acute Cerebral Ischemia
暂无分享,去创建一个
[1] A. Tuttolomondo,et al. Neuroinflammatory Mechanisms in Ischemic Stroke: Focus on Cardioembolic Stroke, Background, and Therapeutic Approaches , 2020, International journal of molecular sciences.
[2] Francesca N. Delling,et al. Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association , 2020, Circulation.
[3] M. Aminoff,et al. Approach to the patient with neurologic disease , 2019 .
[4] P. Whelton,et al. Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis , 2017, JAMA cardiology.
[5] Jun Zhu,et al. Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study , 2016, The Lancet.
[6] Alan D. Lopez,et al. New strategy to reduce the global burden of stroke. , 2015, Stroke.
[7] S. Suissa,et al. Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes. , 2014, European heart journal.
[8] Yong-Ku Kim,et al. The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[9] A. Go,et al. Detection of Paroxysmal Atrial Fibrillation by 30-Day Event Monitoring in Cryptogenic Ischemic Stroke: The Stroke and Monitoring for PAF in Real Time (SMART) Registry , 2012, Stroke.
[10] K. Nave,et al. Neuroinflammation by Cytotoxic T-Lymphocytes Impairs Retrograde Axonal Transport in an Oligodendrocyte Mutant Mouse , 2012, PloS one.
[11] S. Yusuf,et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study , 2010, The Lancet.
[12] R. D'Agostino,et al. Prevalence and Correlates of Silent Cerebral Infarcts in the Framingham Offspring Study , 2008, Stroke.
[13] D. Granger,et al. Cell adhesion molecules and ischemic stroke , 2008, Neurological research.
[14] A. Singleton,et al. Whole Genome Analyses Suggest Ischemic Stroke and Heart Disease Share an Association With Polymorphisms on Chromosome 9p21 , 2008, Stroke.
[15] A. Folsom,et al. Risk Factors for Ischemic Stroke Subtypes: The Atherosclerosis Risk in Communities Study , 2006, Stroke.
[16] J. Kriz. Inflammation in ischemic brain injury: timing is important. , 2006, Critical reviews in neurobiology.
[17] B. Psaty,et al. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups , 2004, Neurology.
[18] C. Wolfe,et al. Cause of Stroke Recurrence Is Multifactorial: Patterns, Risk Factors, and Outcomes of Stroke Recurrence in the South London Stroke Register , 2003, Stroke.
[19] G. Hankey. Long-Term Outcome after Ischaemic Stroke/Transient Ischaemic Attack , 2003, Cerebrovascular Diseases.
[20] Sudha Seshadri,et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. , 2002, JAMA.
[21] F. Barone,et al. Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] Martin A. Samuels,et al. ADAMS AND VICTOR'S PRINCIPLES OF NEUROLOGY , 2010, Neurology.
[23] G. Murray,et al. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study , 1997, BMJ.